Cited by 465Genomics and Rare DiseasesHereditary Neurological DisordersGenetics and Neurodevelopmental Disorders

Accelerating Novel Candidate Gene Discovery in Neurogenetic Disorders via Whole-Exome Sequencing of Prescreened Multiplex Consanguineous Families

Open access
Alazami, Anas M., Patel, Nisha, Shamseldin, Hanan E., Anazi, Shamsa, Al-Dosari, Mohammed S., Alzahrani, Fatema, Hijazi, Hadia, Alshammari, Muneera +45 more·2015·Cell Reports

Abstract

Our knowledge of disease genes in neurological disorders is incomplete. With the aim of closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous families in whom known disease genes had been excluded by autozygosity mapping and candidate gene analysis. This prescreening step led to the identification of 69 recessive genes not previously associated with disease, of which 33 are here described (SPDL1, TUBA3E, INO80, NID1, TSEN15, DMBX1, CLHC1, C12orf4, WDR93, ST7, MATN4, SEC24D, PCDHB4, PTPN23, TAF6, TBCK, FAM177A1, KIAA1109, MTSS1L, XIRP1, KCTD3, CHAF1B, ARV1, ISCA2, PTRH2, GEMIN4, MYOCD, PDPR, DPH1, NUP107, TMEM92, EPB41L4A, and FAM120AOS). We also encountered instances in which the phenotype departed significantly from the established clinical presentation of a known disease gene. Overall, a likely causal mutation was identified in >73% of our cases. This study contributes to the global effort toward a full compendium of disease genes affecting brain function.

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2014.12.015

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CACNA1G loss-of-function mutations are associated with schizophrenia and intellectual disability.

    “The thalamus-enriched voltage-dependent calcium channel CaV3.1 encoded by the Wnt target CACNA1G is the key mediator of thalamocortical connectivity, and putative loss-of-function mutations of CACNA1G have been associated with schizophrenia and intellectual disability [65–67].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alazami, A. M., Patel, N., Shamseldin, H. E., Anazi, S., Al-Dosari, M. S., Alzahrani, F., Hijazi, H., Alshammari, M., Aldahmesh, M. A., Salih, M. A., Faqeih, E., Alhashem, A., Bashiri, F. A., Al-Owain, M., Kentab, A. Y., Sogaty, S., Al Tala, S., Temsah, M.-H., Tulbah, M., Aljelaify, R. F., Alshahwan, S. A., Seidahmed, M. Z., Alhadid, A. A., Aldhalaan, H., AlQallaf, F., Kurdi, W., Alfadhel, M., Babay, Z., Alsogheer, M., Kaya, N., Al-Hassnan, Z. N., Abdel-Salam, G. M. H., Al-Sannaa, N., Al Mutairi, F., El Khashab, H. Y., Bohlega, S., Jia, X., Nguyen, H. C., Hammami, R., Adly, N., Mohamed, J. Y., Abdulwahab, F., Ibrahim, N., Naim, E. A., Al-Younes, B., Meyer, B. F., Hashem, M., Shaheen, R., Xiong, Y., Abouelhoda, M., Aldeeri, A. A., Monies, D. M., & Alkuraya, F. S.
Affiliations
  • King Faisal Specialist Hospital & Research Centre (SA)
  • King Saud University (SA)
  • King Fahd Medical City (SA)
  • Riyadh Armed Forces Hospital (SA)
  • King Fahad Hospital Jeddah (SA)
  • King Abdulaziz City for Science and Technology (SA)
  • Security Forces Hospital (SA)
  • King Saud bin Abdulaziz University for Health Sciences (SA)
  • Saudi Aramco Medical Services Organization (SA)
  • Yale University (US)
Corresponding author
Alkuraya, Fowzan S.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2015-01
Volume
10
Issue
2
Pages
148-161
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2098644602
Cited by
465
References
2
Citations by year
2026: 25 · 2025: 43 · 2024: 29 · 2023: 39 · 2022: 45 · 2021: 42 · 2020: 48 · 2019: 38 · 2018: 42 · 2017: 39 · 2016: 46 · 2015: 27 · 2014: 1
FWCI
24.67
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
neurogenetic disorders, candidate gene identification, consanguineous family, homozygosity mapping, multiplex families, novel disease genes, genotype-phenotype discordance, candidate gene association, exome sequencing
MeSH terms
Central Nervous System Diseases, Chromosome Mapping, Female, Homozygote, Humans, Male, Pedigree, Phenotype, Sequence Analysis, DNA, Polymorphism, Single Nucleotide, Genetic Association Studies, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review